Showing results (81-90 of 112) with videos related to
Sort By:
Pageof 12
Journal of Translational Medicine|June 23, 2026
Sodium-glucose cotransporter 2 inhibitors in breast cancer patients on endocrine therapy: a targeted strategy to mitigate long-term cardiometabolic riskVincenzo Quagliariello, Massimiliano Berretta, Irma Bisceglia, et al.Cancers|July 12, 2025
Impact of Proton Pump Inhibitor Use on Progression-Free and Overall Survival in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis of Recent StudiesGiuliana Ciappina, Alessandro Ottaiano, Mariachiara Santorsola, et al.ACS Nano|August 19, 2017
Enhanced Drug Delivery into Cell Cytosol via Glycoprotein H-Derived Peptide Conjugated NanoemulsionsTeresa Fotticchia, Raffaele Vecchione, Pasqualina Liana Scognamiglio, et al.Cancers|April 14, 2025
In the Era of Cardiovascular-Kidney-Metabolic Syndrome in Cardio-Oncology: From Pathogenesis to Prevention and TherapyVincenzo Quagliariello, Massimiliano Berretta, Irma Bisceglia, et al.International Journal of Molecular Sciences|July 29, 2025
PCSK9 Inhibitor Inclisiran Attenuates Cardiotoxicity Induced by Sequential Anthracycline and Trastuzumab Exposure via NLRP3 and MyD88 Pathway InhibitionVincenzo Quagliariello, Massimiliano Berretta, Irma Bisceglia, et al.Giornale Italiano Di Cardiologia (2006)|September 27, 2021
[ANMCO Position paper: Cardio-oncology in the COVID-19 era]Irma Bisceglia, Domenico Gabrielli, Maria Laura Canale, et al.European Heart Journal Supplements : Journal of the European Society of Cardiology|August 30, 2021
ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO)Irma Bisceglia, Domenico Gabrielli, Maria Laura Canale, et al.Journal of Cardiovascular Pharmacology|September 26, 2025
Time to Combinatorial Regimens: SGLT2i and PCSK9i in High-Risk Cardio-Oncology PatientsVincenzo Quagliariello, Massimiliano Berretta, Irma Bisceglia, et al.Frontiers in Cardiovascular Medicine|December 12, 2022
Women at heart: Introducing gender cardio-oncologyMaria Laura Canale, Irma Bisceglia, Giuseppina Gallucci, et al.Journal of Cardiovascular Development and Disease|December 22, 2022
Combination of Spirulina platensis, Ganoderma lucidum and Moringa oleifera Improves Cardiac Functions and Reduces Pro-Inflammatory Biomarkers in Preclinical Models of Short-Term Doxorubicin-Mediated Cardiotoxicity: New Frontiers in Cardioncology?Vincenzo Quagliariello, Manuela Giovanna Basilicata, Giacomo Pepe, et al.Pageof 12